Acquisitions (Tables)

12 Months Ended

Dec. 31, 2013

Business Acquisition, Pro Forma Information

The pro forma financial information is not necessarily indicative of the results of operations as they would have been had the transaction been effected on the assumed date.




	Year Ended December 31,
	2013			2012
	(in thousands, except per share amounts)
Net revenue	$	695,131		$	626,194
Net loss	$	(24,512	)	$	(94,857	)
Basic loss per common share	$	(0.42	)	$	(1.77	)
Diluted loss per common share	$	(0.42	)	$	(1.77	)

Incline Therapeutics, Inc. [Member]

Business Acquisition [Line Items]

Schedule of Business Acquisitions, by Acquisition

Total purchase price is summarized as follows:



	(in thousands)
Upfront cash consideration	$	186,699
Fair value of contingent purchase price	87,200
Total preliminary estimated purchase price	$	273,899

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

Below is a summary which details the allocation of assets acquired and liabilities assumed as a result of this acquisition:




Assets Acquired:	(in thousands)
Cash and cash equivalents	$	1,563
Prepaid expenses and other current assets	624
Fixed assets, net	12,577
In-process research and development	250,000
Goodwill	102,613
Other assets	34
Total Assets	$	367,411
Liabilities Assumed:
Accrued expenses	$	1,413
Contingent purchase price	87,200
Deferred tax liabilities	92,099
Total Liabilities	$	180,712

Total cash price paid upon acquisition	$	186,699

BMS [Member]

Business Acquisition [Line Items]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

Below is a summary which details the purchase price allocation of assets acquired as a result of this acquisition:




Assets Acquired:	(in thousands)
Product license	$	32,000
Option	62,000
Goodwill	21,000
Total Assets	$	115,000
Total cash price paid upon acquisition	$	115,000

ProFibrix [Member]

Business Acquisition [Line Items]

Schedule of Business Acquisitions, by Acquisition

Total purchase price is summarized as follows:



	(in thousands)
Upfront cash consideration	$	105,395
Fair value of contingent purchase price	82,550
Total estimated purchase price	$	187,945

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

Below is a summary which details the allocation of assets acquired and liabilities assumed as a result of this acquisition:




Assets Acquired:	(in thousands)
Cash	$	7,880
Prepaid assets	528
Fixed assets, net	124
In-process research and development	176,000
Goodwill	52,037
Total Assets	$	236,569
Liabilities Assumed:
Accounts payable	$	1,074
Accrued expenses	3,544
Contingent purchase price	82,550
Deferred tax liabilities	44,006
Total Liabilities	$	131,174

Total cash price paid upon acquisition	$	105,395

Rempex [Member]

Business Acquisition [Line Items]

Schedule of Business Acquisitions, by Acquisition

Total estimated purchase price is summarized as follows:



	(in thousands)
Estimated upfront cash consideration	$	140,251
Estimated fair value of contingent cash payment	96,700
Total preliminary estimated purchase price	$	236,951

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

Below is a summary which details the preliminary allocation of assets acquired based on a preliminary estimate of the fair value of assets acquired and liabilities assumed as a result of this acquisition:





Cash and cash equivalents	$	4,218
Accounts receivable, net	399
Inventory	566
Prepaid expenses and other current assets	2,465
Fixed assets, net	331
Intangible assets	530
In-process research and development	224,680
Goodwill	68,570
Total Assets	301,759
Liabilities Assumed:
Accounts payable	1,413
Accrued expenses	5,805
Deferred tax liabilities	57,590
Total Liabilities	64,808

Total preliminary estimated purchase price	$	236,951